BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2024 3:11:19 PM | Browse: 298 | Download: 1225
Publication Name World Journal of Diabetes
Manuscript ID 93839
Country China
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Basic Study
Article Title Corilagin alleviates podocyte injury in diabetic nephropathy by regulating autophagy via the SIRT1-AMPK pathway
Manuscript Source Unsolicited Manuscript
All Author List Yu Lou, Yu-Ting Luan, Wen-Qing Rong and Yun Gai
ORCID
Author(s) ORCID Number
Yun Gai http://orcid.org/0000-0002-8718-2315
Funding Agency and Grant Number
Funding Agency Grant Number
Shanghai Pudong New Area Leading Talents Training Program Project PWR12020-02
Shanghai Pudong New Area Excellent Young Medical Talents Training Program Project PWRq2023-40
Shanghai Pudong New Area Health and Family Planning Scientific Research Project PW2022A-91
Corresponding Author Yun Gai, PhD, Chief Physician, Department of General Practice (Including Medical Oncology), Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, No. 358 Datong Road, Shanghai 200137, China. gaiyunlucky@163.com
Key Words Corilagin; Podocyte injury; Diabetic nephropathy; Autophagy; High-glucose; SIRT1-AMPK pathway
Core Tip This study explored the protective roles of Corilagin (Cor) against podocyte injury in diabetic nephropathy (DN). The Cor treatment markedly attenuated fasting blood glucose, glycosylated hemoglobin, triglycerides, total cholesterol, increased nephrin and podocin expression, reduced apoptosis rate, inhibited inflammatory cytokines expression and oxidative stress. In addition, Cor contributed to improving the SIRT1 and AMPK expression, inhibited reactive oxygen species and oxidative stress and elevated autophagy in high-glucose-induced podocytes. Thus, Cor might be a potential therapeutic agent for the treatment and clinical management of DN.
Publish Date 2024-08-27 15:11
Citation

Lou Y, Luan YT, Rong WQ, Gai Y. Corilagin alleviates podocyte injury in diabetic nephropathy by regulating autophagy via the SIRT1-AMPK pathway. World J Diabetes 2024; 15(9): 1916-1931

URL https://www.wjgnet.com/1948-9358/full/v15/i9/1916.htm
DOI https://dx.doi.org/10.4239/wjd.v15.i9.1916
Full Article (PDF) WJD-15-1916-with-cover.pdf